eria and monitoring
procedures, as well as any other information that the IRB deems necessary to make its
decision. The sponsor should inform the IRB whether other IRBs have reviewed the proposed
study and what determination was made. The sponsor must inform the IRB of the Agency's
assessment of the device's risk if such an assessment has been made. The IRB may also
consult with FDA for its opinion. </p>

<p>The IRB may agree or disagree with the sponsor's initial NSR assessment. If the IRB
agrees w